XM does not provide services to residents of the United States of America.
A
A

AnalogDevices

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Tesla Inc TSLA.OQ +6.4% Alphabet Inc GOOGL.OQ +4.5% Alphabet Inc GOOG.OQ +4.4% Adobe Inc ADBE.OQ +4.3% PDD Holdings Inc PDD.OQ +4.2% Bottom Performers Percent Change Analog Devices Inc ADI.OQ -1.5% Texas Instruments Inc TXN.OQ -1.2% Intuitive Surgical Inc ISRG.OQ -0.9% Sirius XM Holdings Inc SIRI.OQ -0.9% Lululemon Athletica Inc LULU.OQ -0.9% The Nasdaq 100 .NDX gained 221.27 poin
A
G
L
T
A
S
T
U
P

Nasdaq top and bottom performing stocks at about 12:02 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 12:02 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Tesla Inc TSLA.OQ +6.1% Alphabet Inc GOOGL.OQ +5.9% Alphabet Inc GOOG.OQ +5.8% PDD Holdings Inc PDD.OQ +4.4% PepsiCo Inc PEP.OQ +4.0% Bottom Performers Percent Change DoorDash Inc DASH.OQ -1.6% Electronic Arts Inc EA.OQ -0.9% Lululemon Athletica Inc LULU.OQ -0.8% Zscaler Inc ZS.OQ -0.7% Analog Devices Inc ADI.OQ -0.5% The Nasdaq 100 .NDX gained 221.73 points, or 1.25%, to 18,029.9
G
L
P
T
A
E
U
P

ADI Announces US FDA 510(k) Clearance, Commercial Launch Of Sensinel By Analog Devices Cardiopulmonary Management System

BRIEF-ADI Announces US FDA 510(k) Clearance, Commercial Launch Of Sensinel By Analog Devices Cardiopulmonary Management System March 5 (Reuters) - Analog Devices Inc ADI.O : ADI ANNOUNCES U.S. FDA 510(K) CLEARANCE AND THE COMMERCIAL LAUNCH OF SENSINEL BY ANALOG DEVICES™ CARDIOPULMONARY MANAGEMENT (CPM) SYSTEM Source text for Eikon: ID:nPnZR1fja F
A

US Senator urges chipmakers to help keep their chips out of Russian weapons

UPDATE 1-US Senator urges chipmakers to help keep their chips out of Russian weapons Adds Analog Devices comment By Karen Freifeld Feb 27 (Reuters) - U.S. semiconductor manufacturers should do more to keep their chips from illegally making their way into equipment used by the Russian military, U.S. Senator Richard Blumenthal said at a hearing on Tuesday.
I
A
A
T

US chipmakers should do more to keep chips out of Russian weapons, senator says

US chipmakers should do more to keep chips out of Russian weapons, senator says By Karen Freifeld Feb 27 (Reuters) - U.S. semiconductor manufacturers should do more to keep their chips from illegally making their way into equipment used by the Russian military, U.S. Senator Richard Blumenthal said at a hearing on Tuesday. Blumenthal's comments came as reports show U.S.-origin chips and other technology continue to be found in a wide range of Russian equipment on the battlefield in Ukraine, from
I
A
A
T

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.